Tests:Alpha Fetoprotein, Tumor Marker: Difference between revisions

From Taranaki Lab Manual
Tests:Alpha Fetoprotein, Tumor Marker
Jump to navigation Jump to search
No edit summary
No edit summary
Line 20: Line 20:
|Turnaround Time
|Turnaround Time
|1 hour to 3 days.
|1 hour to 3 days.
|-
|Stability – Add test
|
|-
|-
! colspan="2" |''Specimen Requirements''
! colspan="2" |''Specimen Requirements''
|-
|-
|Specimen Type
|Specimen Type
|7 mL Plain <span style="background:#e30022"> red-top </span>
|Serum
Plasma
|-
|-
|Preferred
|Preferred
|
|7 mL Plain <span style="background:#e30022"> red-top </span>
|-
|-
|Acceptable
|Acceptable
Line 38: Line 42:
|-
|-
|Sample Type
|Sample Type
|
|Serum 
|-
|-
|Minimum Volume
|Minimum Volume
|200 µL Serum 
|200 µL  
|-
|-
|Aliquot Transportation
|Aliquot Transportation
|
|-
|Stability – Add test
|
|
|-
|-

Revision as of 08:50, 31 January 2025


Overview

Department Biochemistry 
Test Code TAFP
Synonyms Tumour Marker (AFP)

AFP (tumour marker)

Turnaround Time 1 hour to 3 days.
Stability – Add test
Specimen Requirements
Specimen Type Serum

Plasma

Preferred 7 mL Plain red-top
Acceptable
Pediatric Requirements Blood 0.5 mL Plain  
Aliquot Requirements
Sample Type Serum 
Minimum Volume 200 µL
Aliquot Transportation
Clinical Information
Reference Intervals 0 - 16 µg/L (non-pregnant) 

See comment  

Test Method Ci8200 analyser, Abbott Reagent. 
Advanced Notice Not Required  
Comments
This test is useful as a tumour marker and as a safe and effective supplement to the management of patients undergoing treatment for non-seminomatous testicular cancer and

certain germ cell cancers, or for patients being monitored after therapy is complete. The test is NOT a screening test for cancer. 

The test is NOT intended as a screen for neural tube defects.

For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.